The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: II. Therapeutic management of atherogenic dyslipidemia.
about
Altered glucose homeostasis and hepatic function in obese mice deficient for both kinin receptor genesTargeting oxidized LDL improves insulin sensitivity and immune cell function in obese Rhesus macaques.CETP inhibitor torcetrapib promotes reverse cholesterol transport in obese insulin-resistant CETP-ApoB100 transgenic mice.Evaluation of a diabetes care program using the effective coverage framework.
P2860
The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: II. Therapeutic management of atherogenic dyslipidemia.
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The obesity, metabolic syndrom ...... t of atherogenic dyslipidemia.
@ast
The obesity, metabolic syndrom ...... t of atherogenic dyslipidemia.
@en
type
label
The obesity, metabolic syndrom ...... t of atherogenic dyslipidemia.
@ast
The obesity, metabolic syndrom ...... t of atherogenic dyslipidemia.
@en
prefLabel
The obesity, metabolic syndrom ...... t of atherogenic dyslipidemia.
@ast
The obesity, metabolic syndrom ...... t of atherogenic dyslipidemia.
@en
P2860
P921
P1476
The obesity, metabolic syndrom ...... t of atherogenic dyslipidemia.
@en
P2093
Henry N Ginsberg
Paul R Maccallum
P2860
P304
P356
10.1111/J.1559-4572.2009.00060.X
P577
2009-09-01T00:00:00Z